Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Proellex in Symptomatic Uterine Fibroids (ZPU-003 EXT)
NCT00958334Phase 2Completed
- Sponsor
- Repros Therapeutics Inc.
- Start
- Sep 2006
- Primary completion
- Oct 2008
- Countries
- 1
01
Overview
A Phase 2 trial of telapristone in Uterine Fibroids (UF), sponsored by Repros Therapeutics Inc.. Started Sep 2006; status: completed.
02
Drugs
telapristone
03
Conditions
Uterine Fibroids (UF)
Beyond the preview
Go deeper on NCT00958334.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00958334.